Skip to main content

Cancer Immunology, Immunotherapy

Ausgabe 9/2007

Inhalt (16 Artikel)

Review

Role of IL-21 in immune-regulation and tumor immunotherapy

Emma di Carlo, Daniela de Totero, Tiziana Piazza, Marina Fabbi, Silvano Ferrini

Original Article

The Thomsen-Friedenreich disaccharide as antigen for in vivo tumor targeting with multivalent scFvs

Peter Ravn, Renate Stahn, Antje Danielczyk, Dorian Faulstich, Uwe Karsten, Steffen Goletz

Original Article

A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33

Satoko Matsueda, Akira Yamada, Yukari Takao, Mayumi Tamura, Nobukazu Komatsu, Shigeru Yutani, Tatsuya Ide, Michio Sata, Kyogo Itoh

Original Article

Development of anti-PAX3 immune responses; a target for cancer immunotherapy

Nourredine Himoudi, Steven Nabarro, Mengyong Yan, Kimberly Gilmour, Adrian J. Thrasher, John Anderson

Original Article

Adoptive therapy of head and neck squamous cell carcinoma with antibody coated immune cells: a pilot clinical trial

Herbert Riechelmann, Markus Wiesneth, Peter Schauwecker, Peter Reinhardt, Silke Gronau, Anita Schmitt, Carsten Schroen, Judith Atz, Michael Schmitt

Original Article

Increase in CD30 ligand/CD153 and TNF-α expressing mast cells in basal cell carcinoma

Nicolae-Costin Diaconu, Renata Kaminska, Anita Naukkarinen, Rauno J. Harvima, Gunnar Nilsson, Ilkka T. Harvima

Original Article

Interleukin 21 therapy increases the density of tumor infiltrating CD8+ T cells and inhibits the growth of syngeneic tumors

Henrik Søndergaard, Klaus S. Frederiksen, Peter Thygesen, Elisabeth D. Galsgaard, Kresten Skak, Paul E. G. Kristjansen, Niels Ødum, Michael Kragh

Original Article

Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment

Christoph Bergmann, Laura Strauss, Reinhard Zeidler, Stephan Lang, Theresa L. Whiteside

Original Article

Induction of protective immune responses against NXS2 neuroblastoma challenge in mice by immunotherapy with GD2 mimotope vaccine and IL-15 and IL-21 gene delivery

Aleksandra Kowalczyk, Andrzej Wierzbicki, Margaret Gil, Barbara Bambach, Yutaro Kaneko, Hanna Rokita, Elizabeth Repasky, Robert Fenstermaker, Martin Brecher, Michael Ciesielski, Danuta Kozbor

Original Article

Density of DC-LAMP+ mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor

Andrea Ladányi, Judit Kiss, Beáta Somlai, Katalin Gilde, Zsuzsanna Fejős, Anita Mohos, István Gaudi, József Tímár

Original Article

Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers

Inge Marie Svane, Anders E. Pedersen, Julia S. Johansen, Hans E. Johnsen, Dorte Nielsen, Claus Kamby, Svend Ottesen, Eva Balslev, Eva Gaarsdal, Kirsten Nikolajsen, Mogens H. Claesson

Open Access Original Article

No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies

Janet W. de Beukelaar, Georges M. Verjans, Yvette van Norden, Johannes C. Milikan, Jaco Kraan, Herbert Hooijkaas, Kees Sintnicolaas, Jan W. Gratama, Peter A. Sillevis Smitt

Short Communication

Long-term immunity elicited by antibody–cytokine fusion proteins protects against sequential challenge with murine mammary and colon malignancies

Gustavo Helguera, José A. Rodríguez, Tracy R. Daniels, Manuel L. Penichet

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.